Baird Downgrades Aprea (APRE) to Neutral on Trial Failure
Go back to Baird Downgrades Aprea (APRE) to Neutral on Trial Failure| Aperture Health, Inc. (NASDAQ: APRE) | Delayed: 0.48 -0.01 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.49 | 52 Week High | $0.08 | |||
| Open | $0.48 | 52 Week Low | $0.00 | |||
| Day High | $0.52 | P/E | N/A | |||
| Day Low | $0.46 | EPS | $0.00 | |||
| Volume | 167,609 | |||||



